ZYME · Zymeworks Inc.

$23.12 -0.24 (-1.03%) At close · Jul 23

Market Cap

$1.69B

73.02M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kenneth Galbraith	CEO	$654,833	—	$2,112,000	$1,985,672	$361,652	$139,459	$5,253,616
Leone Patterson	CFO	$161,667	$50,000	—	$2,590,403	$99,849	$6,063	$2,907,982
Paul Moore	Chief Scientific Officer	$494,683	—	$633,600	$595,702	$214,102	$48,716	$1,986,803

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kenneth Galbraith	CEO	$625,452	—	$1,144,000	$1,194,627	$321,651	$89,146	$3,374,876
Neil Klompas	COO	$321,568	—	$468,000	$328,363	—	$1,007,801	$2,125,732
Paul Moore	Chief Scientific Officer	$465,784	—	$412,000	$397,571	$182,120	$224,762	$1,682,237
Christopher Astle	CFO	$410,093	—	$252,000	$257,602	$124,895	$147,230	$1,191,820

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kenneth Galbraith	CEO	$582,481	—	$879,000	$5,044,999	$537,728	$81,249	$7,125,457
Neil Klompas	COO	$503,795	—	—	$950,036	$330,699	$23,878	$1,808,408
Christopher Astle	CFO	$358,749	—	—	$593,772	$203,048	$159,436	$1,315,005
Ali Tehrani	CEO	$105,742	—	—	—	—	$858,501	$964,243

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ali Tehrani	CEO	$593,092	—	$870,500	$3,625,121	—	$21,924	$5,110,637
Neil Josephson	Chief Medical Officer	$456,653	—	$548,075	$2,525,523	—	$17,438	$3,547,690
Anthony Polverino	Former Executive VP, Early Development & Chief ScientificOfficer	$440,800	—	$282,913	$1,178,164	—	$16,031	$1,917,908
Neil Klompas	COO	$437,124	—	$282,913	$1,178,164	—	$2,277	$1,900,478
Diana Hausman	Former Chief Medical Officer	$173,792	—	$282,913	$1,178,164	—	$11,220	$1,646,089
James Priour	Former Chief Commercial Officer	$400,000	—	$217,625	$906,280	—	$17,438	$1,541,343

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ali Tehrani	CEO	$573,036	—	$814,000	$3,185,803	$283,653	$20,967	$4,877,459
Diana Hausman	Former Chief Medical Officer	$449,946	—	$264,000	$1,033,233	$166,480	$20,188	$1,933,847
Anthony Polverino	Former Executive VP, Early Development & Chief ScientificOfficer	$428,000	—	$264,000	$1,033,233	$158,360	$20,348	$1,903,941
Neil Klompas	CFO	$424,424	—	$264,000	$1,033,233	$163,403	$2,037	$1,887,097

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ali Tehrani	CEO	$540,788	—	—	$2,375,128	$341,930	$20,223	$3,278,069
Neil Klompas	CFO	$379,082	—	—	$1,060,041	$172,422	$12,629	$1,624,174
Diana Hausman	Former Chief Medical Officer	$432,640	—	—	$758,019	$192,525	$21,341	$1,404,525
Anthony Polverino	Former Executive VP, Early Development & Chief ScientificOfficer	$400,000	—	—	$758,019	$178,000	$384	$1,336,403

Key facts CIK 1937653 CUSIP 98985Y108 13F (30d) 23 filings 23 filers Visit website Investor relations